Score Breakdown
Offering Ability
60
Cash Runway
40
Float Risk
12
Warrant Exposure
40
Convertible Debt
40
Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
model est. 27%
🔄 Reverse Split
model est. 55%
• 50-day avg $0.07 below $1 exchange minimum
Market Data
Market Cap$400.1K
Shares Outstanding4.66M
Float4.12M
Cash$3.8K
Debt$523.9K
Short InterestN/A
Institutional Holdings
2 institutional holders · 2 shares
#1
LRI Investments, LLC
1 shares
#2
DANSKE BANK A/S
1 shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest16.9K
Days to Cover2.2
% of Float0.4%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2020-12-01
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual CYTOF Dilution Snapshot
Altamira Therapeutics Ltd. (CYTOF) has a DilutionScore of 41/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for CYTOF: xbrl on 2020-12-01.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles: